Information Obtained from the Walton Centre-Medical Services Neurology and Long Term Conditions in England
The Walton Centre for Neurology and Neurosurgery NHS Trust
Lower Lane
Fazakerley
Liverpool
L9 7LJ
17. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003;60(5):848-53.
18. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006;66(10):1485-9.
19. Pittock SJ, Lennon VA, Wingerchuk DM, Homburger HA, Lucchinetti CF, Weinshenker BG. The prevalence of non-organ-specific autoantibodies and NMO-IgG in neuromyelitis optica (NMO) and related disorders. Neurology 2006; 66(5 Suppl 2):A307.
20. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Lucchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006;63(3):390-6.
21. Jacob A, Das K, Nicholas R, Boggild M. Neuromyelitis optica (Devic's disease) in the United Kingdom: epidemiology, clinical, radiological and therapy profile in the first 42 patients. American Academy of Neurology 57th Annual Meeting; April 9-16, 2005; . 2005:Abstract PO5.133.
21. Nakashima I, Fujihara K, Miyazawa I, Misu T, Narikawa K, Nakamura M, et al. Clinical and MRI features of Japanese MS patients with NMO-IgG. J Neurol Neurosurg Psychiatry 2006.
22. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003;4(12):991-1001.
23. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005;202(4):473-7.
24. Jacob A, Boggild M. Neuromyelitis optica. Practical neurology 2006(6):180-184.
25. Wingerchuk DM. Neuromyelitis optica: current concepts. Front Biosci 2004;9:834-40.
26. Keegan M, Pineda AA, McClelland RL, Darby CH, Rodriguez M, Weinshenker BG. Plasma exchange for severe attacks of CNS demyelination: predictors of response. Neurology 2002;58(1):143-6.
27. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998;51(4):1219-20.
28. Falcini F, Trapani S, Ricci L, Resti M, Simonini G, de Martino M. Sustained improvement of a girl affected with Devic's disease over 2 years of mycophenolate mofetil treatment. Rheumatology (Oxford) 2006;45(7):913-5.
29. Weinstock-Guttman B, Ramanathan M, Lincoff N, Napoli SQ, Sharma J, Feichter J, et al. Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 2006;63(7):957-63.
30. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005;64(7):1270-2.
31. Bonnet F, Mercie P, Morlat P, Hocke C, Vergnes C, Ellie E, et al. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus. Lupus 1999;8(3):244-7.
32. Bakker J, Metz L. Devic's neuromyelitis optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 2004;31(2):265-7.
33. Bergamaschi R, Uggetti C, Tonietti S, Egitto MG, Cosi V. A case of relapsing neuromyelitis optica treated with glatiramer acetate. J Neurol 2003;250(3):359-61.
34. Papeix C, Deseze J, Pierrot-Deseilligny C, Tourbah A, Lebrun C, Moreau T, et al. French Therapeutic Experience of Devic's Disease: A Retrospective Study of 33 Cases. Neurology 2005;64((Suppl 1)): A328.
35. de Seze J. [Devic's neuromyelitis optica: an evolving concept]. Rev Neurol (Paris) 2006;162(5):565-6.
36. Misu T, Fujihara K, Nakamura M, Murakami K, Endo M, Konno H, et al. Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. Tohoku J Exp Med 2006;209(3):269-75.
37. Filippi M, Rocca MA. MR imaging of Devic's neuromyelitis optica. Neurol Sci 2004;25 Suppl 4:S371-3.
The Walton Centre for Neurology and Neurosurgery NHS Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ
Tel: 0151 525 3611 Fax: 0151 529 5500
The Walton Centre for Neurology and Neurosurgery NHS Trust, Lower Lane, Fazakerley, Liverpool L9 7LJ
Tel: 0151 525 3611 Fax: 0151 529 5500
Please make sure to speak to your Doctor, Neurologist before making any Medical decisions.
DISCLAIMER:
Please make sure to check with your Doctor, Neurologist before making any medical decision. Information on this site is information found during the research of Devic's Disease.
Information obtianed from the Walton Centre website
Permission obtained from the Walton Centre by Lousie Douglas
Louise Douglas
Head of Marketing and Communications
The Walton Centre for neurology and neurosurgery NHS Trust
Neuro-care beyond compare
Copyright(s) belong to the Walton Centre-Medical Services
